Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common cause of
chronic liver disease due to an increase in the prevalence of obesity. The development of …

Non-alcoholic fatty liver disease (NAFLD) has become one of the most prominent forms of
chronic liver disease worldwide, reflecting the epidemic of global obesity. Those with the …

Background & Aims Obeticholic acid (OCA; INT-747, 6α-ethyl-chenodeoxycholic acid) is a
semisynthetic derivative of the primary human bile acid chenodeoxycholic acid, the natural …

Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are serious
health problems worldwide. These two diseases have similar pathological spectra, ranging …

Non-alcoholic fatty liver disease (NAFLD) is a clinicopathological change characterized by
the accumulation of triglycerides in hepatocytes and has frequently been associated with …

Non-Alcoholic Fatty Liver Disease (NAFLD) is now the most prevalent form of chronic liver
disease, affecting 10%–20% of the general paediatric population. Within the next 10 years it …

Bile salts play crucial roles in allowing the gastrointestinal system to digest, transport and
metabolize nutrients. They function as nutrient signaling hormones by activating specific …

As the global incidence of obesity has increased, nonalcoholic fatty liver disease (NAFLD)
has become a worldwide health concern. NAFLD occurs in children and adults of all …

Reactive oxygen species, when released under controlled conditions and limited amounts,
contribute to cellular proliferation, senescence, and survival by acting as signaling …

Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disorder that is increasing in
prevalence with the worldwide epidemic of obesity. NAFLD is the hepatic manifestation of …